MB Mereo BioPharma Group plc Stock: price and directors' dealings · United States · SEC (Form 4)Track the Mereo BioPharma Group plc stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €54.7m. The latest transaction was filed on 16 September 2024 (Cession). Among the most active insiders: Hughes-Wilson Alexandra. All data is free.
€539,820
10 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate Mereo BioPharma Group plc Buy (bullish), based on 5 analysts. Average price target: US$1.98.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,511 of 29,064 companies
FCF yld -57%
Earn yld -77%
EV/EBITDA ·
ROE -76%
Gross mgn 73%
Net mgn ·
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 September 2024
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
▼ Chief Financial Officer · Executives · 12 Sept 2024
9,128 shares @ US$4.4727 45.1% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106970:0
▼ See Remarks · Executives · 12 Sept 2024
7,769 shares @ US$4.4727 16.8% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106968:0
▼ Chief Executive Officer · Executives · 12 Sept 2024
28,611 shares @ US$4.4727 45.1% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106976:0
▼ Chief Scientific Officer · Executives · 12 Sept 2024
5,212 shares @ US$4.4727 45.1% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106974:0
▼ General Counsel · Executives · 12 Sept 2024
9,980 shares @ US$4.4727 45.1% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106972:0
◇ See Remarks · Executives · 11 Sept 2024
40,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106413:0
◇ Chief Executive Officer · Executives · 11 Sept 2024
188,060 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106417:0
◇ Chief Financial Officer · Executives · 11 Sept 2024
60,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106419:0
◇ General Counsel · Executives · 11 Sept 2024
65,600 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106426:0
◇ Chief Scientific Officer · Executives · 11 Sept 2024
46,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-106418:0
◇ Director · Executives · 22 Aug 2024
1,825 shares @ US$3.00 100.0% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-100281:0
▼ Chief Scientific Officer · Executives · 25 Jun 2024
7,416 shares @ US$3.6939 54.9% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-078468:0
▼ General Counsel · Executives · 25 Jun 2024
14,202 shares @ US$3.6939 54.9% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-078469:0
▼ Chief Financial Officer · Executives · 25 Jun 2024
12,990 shares @ US$3.6939 54.9% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-078467:0
▼ Chief Executive Officer · Executives · 25 Jun 2024
40,712 shares @ US$3.6939 54.9% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-078465:0
▼ See Remarks · Executives · 25 Jun 2024
10,134 shares @ US$3.6939 18.7% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-078462:0
◇ See Remarks · Executives · 21 Jun 2024
60,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-077479:0
◇ Chief Executive Officer · Executives · 21 Jun 2024
282,090 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-077482:0
◇ Chief Financial Officer · Executives · 21 Jun 2024
90,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-077480:0
◇ Chief Scientific Officer · Executives · 21 Jun 2024
69,000 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-077487:0
◇ General Counsel · Executives · 21 Jun 2024
98,400 shares 0American Depositary Shares representing Ordinary Shares SEC:0000950170-24-077481:0
◆ Director · Executives · 17 Jun 2024
25,050 shares @ US$3.99 100.0% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-074248:0
◆ Director · Executives · 17 Jun 2024
12,550 shares @ US$3.99 100.0% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-074247:0
◇ See Remarks · Executives · 22 May 2024
93,333 shares @ US$1.40 64.5% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-24-064274:0
关于 Mereo BioPharma Group plc Mereo BioPharma Group plc 是一家生物制药公司，专注于开发罕见疾病和年龄相关疾病的治疗方法。该公司在纳斯达克上市，股票代码为 MREO。